Skip to main content
padlock icon - secure page this page is secure

Open Access Autoimmune Hepatitis: Pathophysiology, Diagnosis and Pharmacological Therapy

Download Article:
(PDF 582.9 kb)
Autoimmune hepatitis (AIH) is a chronic inflammatory liver disease, rare and of unknown etiology, that affects patients who lack tolerance to self antigens. Genetic and environmental factors are related to the disease etiology. The pathology, mainly prevalent in females, is characterized by the presence of interface hepatitis with biochemical changes, such as increased levels of transaminase, the presence of hypergammaglobulinemia and circulating autoantibodies. Antibodies classify the types of the disease. Due to the heterogeneity of symptoms, the diagnostic criteria are not unique since they are based on a combination of clinical, biochemical, immunological and histological features. AIH should be diagnosed in its early stages due to possible cirrhosis evolution when untreated. Standard and most effective treatment consists of corticosteroids in combination or not with azathioprine. AIH has a good prognosis with good resolution of symptoms when properly treated, albeit with relapse at an early withdrawal.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Autoimmune hepatitis; diagnosis; non-viral hepatitis; pathophysiology; treatment

Document Type: Research Article

Publication date: November 1, 2012

More about this publication?
  • Current Immunology Reviews publishes frontier reviews on all the latest advances in clinical immunology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in clinical immunology.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more